Cargando…
Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation
Aldehyde dehydrogenase-2 (ALDH2) is a crucial enzyme participating in intracellular aldehyde metabolism and is acknowledged as a potential therapeutic target for the treatment of alcohol use disorder and other addictive behaviors. Using previously reported ALDH2 inhibitors of Daidzin, CVT-10216, and...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650273/ https://www.ncbi.nlm.nih.gov/pubmed/37959744 http://dx.doi.org/10.3390/molecules28217325 |
_version_ | 1785135743219269632 |
---|---|
author | Jiang, Wanyun Chen, Junzhao Zhang, Puyu Zheng, Nannan Ma, Le Zhang, Yongguang Zhang, Haiyang |
author_facet | Jiang, Wanyun Chen, Junzhao Zhang, Puyu Zheng, Nannan Ma, Le Zhang, Yongguang Zhang, Haiyang |
author_sort | Jiang, Wanyun |
collection | PubMed |
description | Aldehyde dehydrogenase-2 (ALDH2) is a crucial enzyme participating in intracellular aldehyde metabolism and is acknowledged as a potential therapeutic target for the treatment of alcohol use disorder and other addictive behaviors. Using previously reported ALDH2 inhibitors of Daidzin, CVT-10216, and CHEMBL114083 as reference molecules, here we perform a ligand-based virtual screening of world-approved drugs via 2D/3D similarity search methods, followed by the assessments of molecular docking, toxicity prediction, molecular simulation, and the molecular mechanics Poisson–Boltzmann surface area (MM–PBSA) analysis. The 2D molecular fingerprinting of ECFP4 and FCFP4 and 3D molecule-shape-based USRCAT methods show good performances in selecting compounds with a strong binding behavior with ALDH2. Three compounds of Zeaxanthin (q = 0), Troglitazone (q = 0), and Sequinavir (q = +1 e) are singled out as potential inhibitors; Zeaxanthin can only be hit via USRCAT. These drugs displayed a stronger binding strength compared to the reported potent inhibitor CVT-10216. Sarizotan (q = +1 e) and Netarsudil (q = 0/+1 e) displayed a strong binding strength with ALDH2 as well, whereas they displayed a shallow penetration into the substrate-binding tunnel of ALDH2 and could not fully occupy it. This likely left a space for substrate binding, and thus they were not ideal inhibitors. The MM–PBSA results indicate that the selected negatively charged compounds from the similarity search and Vina scoring are thermodynamically unfavorable, mainly due to electrostatic repulsion with the receptor (q = −6 e for ALDH2). The electrostatic attraction with positively charged compounds, however, yielded very strong binding results with ALDH2. These findings reveal a deficiency in the modeling of electrostatic interactions (in particular, between charged moieties) in the virtual screening via the 2D/3D similarity search and molecular docking with the Vina scoring system. |
format | Online Article Text |
id | pubmed-10650273 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106502732023-10-29 Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation Jiang, Wanyun Chen, Junzhao Zhang, Puyu Zheng, Nannan Ma, Le Zhang, Yongguang Zhang, Haiyang Molecules Article Aldehyde dehydrogenase-2 (ALDH2) is a crucial enzyme participating in intracellular aldehyde metabolism and is acknowledged as a potential therapeutic target for the treatment of alcohol use disorder and other addictive behaviors. Using previously reported ALDH2 inhibitors of Daidzin, CVT-10216, and CHEMBL114083 as reference molecules, here we perform a ligand-based virtual screening of world-approved drugs via 2D/3D similarity search methods, followed by the assessments of molecular docking, toxicity prediction, molecular simulation, and the molecular mechanics Poisson–Boltzmann surface area (MM–PBSA) analysis. The 2D molecular fingerprinting of ECFP4 and FCFP4 and 3D molecule-shape-based USRCAT methods show good performances in selecting compounds with a strong binding behavior with ALDH2. Three compounds of Zeaxanthin (q = 0), Troglitazone (q = 0), and Sequinavir (q = +1 e) are singled out as potential inhibitors; Zeaxanthin can only be hit via USRCAT. These drugs displayed a stronger binding strength compared to the reported potent inhibitor CVT-10216. Sarizotan (q = +1 e) and Netarsudil (q = 0/+1 e) displayed a strong binding strength with ALDH2 as well, whereas they displayed a shallow penetration into the substrate-binding tunnel of ALDH2 and could not fully occupy it. This likely left a space for substrate binding, and thus they were not ideal inhibitors. The MM–PBSA results indicate that the selected negatively charged compounds from the similarity search and Vina scoring are thermodynamically unfavorable, mainly due to electrostatic repulsion with the receptor (q = −6 e for ALDH2). The electrostatic attraction with positively charged compounds, however, yielded very strong binding results with ALDH2. These findings reveal a deficiency in the modeling of electrostatic interactions (in particular, between charged moieties) in the virtual screening via the 2D/3D similarity search and molecular docking with the Vina scoring system. MDPI 2023-10-29 /pmc/articles/PMC10650273/ /pubmed/37959744 http://dx.doi.org/10.3390/molecules28217325 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jiang, Wanyun Chen, Junzhao Zhang, Puyu Zheng, Nannan Ma, Le Zhang, Yongguang Zhang, Haiyang Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation |
title | Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation |
title_full | Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation |
title_fullStr | Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation |
title_full_unstemmed | Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation |
title_short | Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation |
title_sort | repurposing drugs for inhibition against aldh2 via a 2d/3d ligand-based similarity search and molecular simulation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650273/ https://www.ncbi.nlm.nih.gov/pubmed/37959744 http://dx.doi.org/10.3390/molecules28217325 |
work_keys_str_mv | AT jiangwanyun repurposingdrugsforinhibitionagainstaldh2viaa2d3dligandbasedsimilaritysearchandmolecularsimulation AT chenjunzhao repurposingdrugsforinhibitionagainstaldh2viaa2d3dligandbasedsimilaritysearchandmolecularsimulation AT zhangpuyu repurposingdrugsforinhibitionagainstaldh2viaa2d3dligandbasedsimilaritysearchandmolecularsimulation AT zhengnannan repurposingdrugsforinhibitionagainstaldh2viaa2d3dligandbasedsimilaritysearchandmolecularsimulation AT male repurposingdrugsforinhibitionagainstaldh2viaa2d3dligandbasedsimilaritysearchandmolecularsimulation AT zhangyongguang repurposingdrugsforinhibitionagainstaldh2viaa2d3dligandbasedsimilaritysearchandmolecularsimulation AT zhanghaiyang repurposingdrugsforinhibitionagainstaldh2viaa2d3dligandbasedsimilaritysearchandmolecularsimulation |